The DOI matches its Crossref record; 169 of the 169 references it cites were found in a registry or an index.
Aryl hydrocarbon receptor ligands in cancer: friend and foe
Open accessAbstract
The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that is best known for mediating the toxicity and tumour-promoting properties of the carcinogen 2,3,7,8-tetrachlorodibenzo-p-dioxin, commonly referred to as 'dioxin'. AHR influences the major stages of tumorigenesis — initiation, promotion, progression and metastasis — and physiologically relevant AHR ligands are often formed during disease states or during heightened innate and adaptive immune responses. Interestingly, ligand specificity and affinity vary between rodents and humans. Studies of aggressive tumours and tumour cell lines show increased levels of AHR and constitutive localization of this receptor in the nucleus. This suggests that the AHR is chronically activated in tumours, thus facilitating tumour progression. This Review discusses the role of AHR in tumorigenesis and the potential for therapeutic modulation of its activity in tumours.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632
Zelante, T., Iannitti, R. G., Cunha, C., De Luca, A., Giovannini, G., Pieraccini, G., Zecchi, R., D’Angelo, C., Massi-Benedetti, C., Fallarino, F., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.08.003 · Cited by 2,614
Regulatory T cells, tumour immunity and immunotherapy
Zou, W. (2006) · Nature Reviews Immunology · doi:10.1038/nri1806 · Cited by 2,085
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
Naugler, W. E., Sakurai, T., Kim, S., Maeda, S., Kim, K., Elsharkawy, A. M., & Karin, M. (2007) · Science · doi:10.1126/science.1140485 · Cited by 1,955
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Opitz, C. A., Litzenburger, U. M., Sahm, F., Ott, M., Tritschler, I., Trump, S., Schumacher, T., Jestaedt, L., Schrenk, D., Weller, M., et al. (2011) · Nature · doi:10.1038/nature10491 · Cited by 1,898
Denison, M. S., & Nagy, S. R. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.135828 · Cited by 1,895
Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor
Quintana, F. J., Basso, A. S., Iglesias, A. H., Korn, T., Farez, M. F., Bettelli, E., Caccamo, M., Oukka, M., & Weiner, H. L. (2008) · Nature · doi:10.1038/nature06880 · Cited by 1,865
An Interaction between Kynurenine and the Aryl Hydrocarbon Receptor Can Generate Regulatory T Cells
Mezrich, J. D., Fechner, J. H., Zhang, X., Johnson, B. P., Burlingham, W. J., & Bradfield, C. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903670 · Cited by 1,601
Poland, A., Glover, E., & Kende, A. S. (1976) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33205-2 · Cited by 1,370
Aryl Hydrocarbon Receptor Antagonists Promote the Expansion of Human Hematopoietic Stem Cells
Boitano, A. E., Wang, J., Romeo, R., Bouchez, L. C., Parker, A. E., Sutton, S. E., Walker, J. R., Flaveny, C. A., Perdew, G. H., Denison, M. S., et al. (2010) · Science · doi:10.1126/science.1191536 · Cited by 1,047
Self-citationDenison, M. S., Soshilov, A. A., He, G., DeGroot, D. E., & Zhao, B. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr218 · Cited by 748
The Aryl Hydrocarbon Receptor Complex and the Control of Gene Expression
Beischlag, T. V., Morales, J. L., Hollingshead, B. D., & Perdew, G. H. (2008) · Critical Reviews™ in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v18.i3.20 · Cited by 727
Self-citationApetoh, L., Quintana, F. J., Pot, C., Joller, N., Xiao, S., Kumar, D., Burns, E. J., Sherr, D. H., Weiner, H. L., & Kuchroo, V. K. (2010) · Nature Immunology · doi:10.1038/ni.1912 · Cited by 725
DiNatale, B. C., Murray, I. A., Schroeder, J. C., Flaveny, C. A., Lahoti, T. S., Laurenzana, E. M., Omiecinski, C. J., & Perdew, G. H. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq024 · Cited by 634
Self-citationBjeldanes, L. F., Kim, J. Y., Grose, K. R., Bartholomew, J. C., & Bradfield, C. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.21.9543 · Cited by 588
Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase
Pilotte, L., Larrieu, P., Stroobant, V., Colau, D., Dolušić, E., Frédérick, R., De Plaen, E., Uyttenhove, C., Wouters, J., Masereel, B., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113873109 · Cited by 572
Gandhi, R., Kumar, D., Burns, E. J., Nadeau, M., Dake, B., Laroni, A., Kozoriz, D., Weiner, H. L., & Quintana, F. J. (2010) · Nature Immunology · doi:10.1038/ni.1915 · Cited by 476
He, G., Dhar, D., Nakagawa, H., Font-Burgada, J., Ogata, H., Jiang, Y., Shalapour, S., Seki, E., Yost, S. E., Jepsen, K., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.031 · Cited by 474
Mellor, A. L., Baban, B., Chandler, P., Marshall, B., Jhaver, K., Hansen, A., Koni, P. A., Iwashima, M., & Munn, D. H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.4.1652 · Cited by 455
Indirubin and Indigo Are Potent Aryl Hydrocarbon Receptor Ligands Present in Human Urine
Adachi, J., Mori, Y., Matsui, S., Takigami, H., Fujino, J., Kitagawa, H., Miller, C. A., Kato, T., Saeki, K., & Matsuda, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100238200 · Cited by 407
Ah Receptor and NF-κB Interactions, a Potential Mechanism for Dioxin Toxicity
Tian, Y., Ke, S., Denison, M. S., Rabson, A. B., & Gallo, M. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.510 · Cited by 405
Ciolino, H. P., Daschner, P. J., & Yeh, G. C. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3400715 · Cited by 389
Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis
van den Bogaard, E. H., Bergboer, J. G. M., Vonk-Bergers, M., van Vlijmen-Willems, I. M. J. J., Hato, S. V., van der Valk, P. G. M., Schröder, J. M., Joosten, I., Zeeuwen, P. L. J. M., & Schalkwijk, J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65642 · Cited by 373
Kolluri, S. K., Weiss, C., Koff, A., & Gottlicher, M. (1999) · Genes & Development · doi:10.1101/gad.13.13.1742 · Cited by 364
Inhibitory Aryl Hydrocarbon Receptor−Estrogen Receptor α Cross-Talk and Mechanisms of Action
Safe, S., & Wormke, M. (2003) · Chemical Research in Toxicology · doi:10.1021/tx034036r · Cited by 348
NRF2 Modulates Aryl Hydrocarbon Receptor Signaling: Influence on Adipogenesis
Shin, S., Wakabayashi, N., Misra, V., Biswal, S., Lee, G. H., Agoston, E. S., Yamamoto, M., & Kensler, T. W. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00915-07 · Cited by 348
An expanding range of targets for kynurenine metabolites of tryptophan
Stone, T. W., Stoy, N., & Darlington, L. G. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.09.006 · Cited by 344
Flavonoids as aryl hydrocarbon receptor agonists/antagonists: effects of structure and cell context.
Zhang, S., Qin, C., & Safe, S. H. (2003) · Environmental Health Perspectives · doi:10.1289/ehp.6322 · Cited by 340
Schroeder, J. C., DiNatale, B. C., Murray, I. A., Flaveny, C. A., Liu, Q., Laurenzana, E. M., Lin, J. M., Strom, S. C., Omiecinski, C. J., Amin, S., et al. (2010) · Biochemistry · doi:10.1021/bi901786x · Cited by 330
Self-citationAryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis
Marlowe, J. L., & Puga, A. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20656 · Cited by 329
Jin, U.-H., Lee, S.-O., Sridharan, G., Lee, K., Davidson, L. A., Jayaraman, A., Chapkin, R. S., Alaniz, R., & Safe, S. (2014) · Molecular Pharmacology · doi:10.1124/mol.113.091165 · Cited by 327
Wormke, M., Stoner, M., Saville, B., Walker, K., Abdelrahim, M., Burghardt, R., & Safe, S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.6.1843-1855.2003 · Cited by 325
Litzenburger, U. M., Opitz, C. A., Sahm, F., Rauschenbach, K. J., Trump, S., Winter, M., Ott, M., Ochs, K., Lutz, C., Liu, X., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1637 · Cited by 322
RelB, a New Partner of Aryl Hydrocarbon Receptor-Mediated Transcription
Vogel, C. F. A., Sciullo, E., Li, W., Wong, P., Lazennec, G., & Matsumura, F. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0211 · Cited by 319
Puga, A., Barnes, S. J., Dalton, T. P., Chang, C.-Y., Knudsen, E. S., & Maier, M. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2943 · Cited by 316
CH223191 Is a Ligand-Selective Antagonist of the Ah (Dioxin) Receptor
Zhao, B., DeGroot, D. E., Hayashi, A., He, G., & Denison, M. S. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq217 · Cited by 312
A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors
Andersson, P., McGuire, J., Rubio, C., Gradin, K., Whitelaw, M. L., Pettersson, S., Hanberg, A., & Poellinger, L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152706299 · Cited by 310
Tumour promotion by TCDD in skin of HRS/J hairless mice
Poland, A., Palen, D., & Glover, E. (1982) · Nature · doi:10.1038/300271a0 · Cited by 293
Kim, S.-H., Henry, E. C., Kim, D.-K., Kim, Y.-H., Shin, K. J., Han, M. S., Lee, T. G., Kang, J.-K., Gasiewicz, T. A., Ryu, S. H., et al. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.021832 · Cited by 286
Singh, N. P., Singh, U. P., Singh, B., Price, R. L., Nagarkatti, M., & Nagarkatti, P. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023522 · Cited by 284
Ciolino, H. P., Daschner, P. J., & Yeh, G. C. (1998) · PubMed · Cited by 283
Selective estrogen receptor modulators (SERMs): Mechanisms of anticarcinogenesis and drug resistance
Lewis, J. S., & Jordan, V. C. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2005.02.028 · Cited by 281
Kim, D. W., Gazourian, L., Quadri, S. A., Raphaëlle, Sherr, D. H., & Sonenshein, G. E. (2000) · Oncogene · doi:10.1038/sj.onc.1203945 · Cited by 280
Wincent, E., Amini, N., Luecke, S., Glatt, H., Bergman, J., Crescenzi, C., Rannug, A., & Rannug, U. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808321200 · Cited by 279
Cross-talk between Aryl Hydrocarbon Receptor and the Inflammatory Response
Vogel, C. F. A., Khan, E. M., Leung, P. S. C., Gershwin, M. E., Chang, W. L. W., Wu, D., Haarmann-Stemmann, T., Hoffmann, A., & Denison, M. S. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.505578 · Cited by 273
Bersten, D. C., Sullivan, A. E., Peet, D. J., & Whitelaw, M. L. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3621 · Cited by 267
Role of the Aryl Hydrocarbon Receptor in Carcinogenesis and Potential as a Drug Target
Safe, S., Lee, S.-O., & Jin, U.-H. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft128 · Cited by 264
Does the Immune System Naturally Protect Against Cancer?
Corthay, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00197 · Cited by 261
A Constitutively Active Dioxin/Aryl Hydrocarbon Receptor Promotes Hepatocarcinogenesis in Mice
Moennikes, O., Loeppen, S., Buchmann, A., Andersson, P., Ittrich, C., Poellinger, L., & Schwarz, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0875 · Cited by 228
Hu, W., Sorrentino, C., Denison, M. S., Kolaja, K., & Fielden, M. R. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.032748 · Cited by 225
Beischlag, T. V., & Perdew, G. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500090200 · Cited by 203
Self-citationRole of the aryl hydrocarbon receptor in cell cycle regulation
Puga, A., Xia, Y., & Elferink, C. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00069-8 · Cited by 192
Epiregulin: Roles in normal physiology and cancer
Riese, D. J., & Cullum, R. L. (2014) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2014.03.005 · Cited by 192
Niwa, T., Takeda, N., Tatematsu, A., & Maeda, K. (1988) · Clinical Chemistry · doi:10.1093/clinchem/34.11.2264 · Cited by 188
Aryl hydrocarbon receptor activation by cAMP vs. dioxin: Divergent signaling pathways
Oesch-Bartlomowicz, B., Huelster, A., Wiss, O., Antoniou-Lipfert, P., Dietrich, C., Arand, M., Weiss, C., Bockamp, E., & Oesch, F. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503488102 · Cited by 185
Role of aryl hydrocarbon receptor in cancer
Feng, S., Cao, Z., & Wang, X. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.05.001 · Cited by 179
Sekine, H., Mimura, J., Oshima, M., Okawa, H., Kanno, J., Igarashi, K., Gonzalez, F. J., Ikuta, T., Kawajiri, K., & Fujii-Kuriyama, Y. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00337-09 · Cited by 179
The Aryl Hydrocarbon Receptor Functions as a Tumor Suppressor of Liver Carcinogenesis
Fan, Y., Boivin, G. P., Knudsen, E. S., Nebert, D. W., Xia, Y., & Puga, A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3090 · Cited by 177
p-Cresyl Sulfate and Indoxyl Sulfate in Hemodialysis Patients
Meijers, B. K. I., De Loor, H., Bammens, B., Verbeke, K., Vanrenterghem, Y., & Evenepoel, P. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02940509 · Cited by 177
Magiatis, P., Pappas, P., Gaitanis, G., Mexia, N., Melliou, E., Galanou, M., Vlachos, C., Stathopoulou, K., Skaltsounis, A. L., Marselos, M., et al. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.92 · Cited by 171
AhR acts as an E3 ubiquitin ligase to modulate steroid receptor functions
Ohtake, F., Fujii-Kuriyama, Y., & Kato, S. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.08.034 · Cited by 170
Haarmann-Stemmann, T., Bothe, H., & Abel, J. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.09.013 · Cited by 169
Manchester, D., Gordon, S. K., Golas, C. L., Roberts, E. A., & Okey, A. B. (1987) · PubMed · Cited by 168
Carcinogenicity of 2,3,7,8‐tetrachlorodibenzo‐p‐dioxin in experimental models
Knerr, S., & Schrenk, D. (2006) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200600006 · Cited by 168
Aryl Hydrocarbon Receptor Activation by TCDD Reduces Inflammation Associated with Crohn's Disease
Benson, J. M., & Shepherd, D. M. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfq360 · Cited by 164
Öberg, M., Bergander, L., Håkansson, H., Rannug, U., & Rannug, A. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi154 · Cited by 163
Kerkvliet, N. I., Steppan, L. B., Vorachek, W., Oda, S., Farrer, D., Wong, C. P., Pham, D., & Mourich, D. V. (2009) · Immunotherapy · doi:10.2217/imt.09.24 · Cited by 160
Vorrink, S. U., & Domann, F. E. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.05.001 · Cited by 157
Diry, M., Tomkiewicz, C., Köhle, C., Coumoul, X., Bock, K. W., Barouki, R., & Transy, C. (2006) · Oncogene · doi:10.1038/sj.onc.1209553 · Cited by 157
Sato, A., Shirakawa, H., Tomita, S., Ohsaki, Y., Haketa, K., Tooi, O., Santo, N., Tohkin, M., Furukawa, Y., Gonzalez, F. J., et al. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.12.029 · Cited by 148
Gillner, M., Bergman, J., Cambillau, C., Fernström, B., & Gustafsson, J.-Α. (1985) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14168-0 · Cited by 147
Barhoover, M. A., Hall, J. M., Greenlee, W. F., & Thomas, R. S. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.059675 · Cited by 144
The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasis
Jin, U.-H., Lee, S., Pfent, C. M., & Safe, S. H. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-498 · Cited by 141
Expression of CYP1A1 and CYP1B1 in human endothelial cells: regulation by fluid shear stress
Conway, D. E., Sakurai, Y., Weiss, D., Vega, J. D., Taylor, W. R., Jo, H., Eskin, S. G., Marcus, C. B., & McIntire, L. V. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvn360 · Cited by 139
Chadwick, C. C., Chippari, S. M., Matelan, E. M., Borges-Marcucci, L., Eckert, A. M., Keith, J. C., Albert, L. M., Leathurby, Y., Harris, H. A., Bhat, R. A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405841102 · Cited by 137
Gasiewicz, T. A., & Rucci, G. (1991) · PubMed · Cited by 135
Activation of the Ah Receptor by Extracts of Dietary Herbal Supplements, Vegetables, and Fruits
Jeuken, A., Keser, B., Khan, E. M., Brouwer, A., Koeman, J. H., & Denison, M. S. (2003) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf030252u · Cited by 130
Hollingshead, B. D., Beischlag, T. V., DiNatale, B. C., Ramadoss, P., & Perdew, G. H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6168 · Cited by 128
Self-citationQuattrochi, L. C., & Tukey, R. H. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13403-2 · Cited by 126
Henry, E. C., Kende, A. S., Rucci, G., Totleben, M. J., Willey, J. J., Dertinger, S. D., Pollenz, R. S., Jones, J. P., & Gasiewicz, T. A. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23034-0 · Cited by 126
Cell Density Regulates Intracellular Localization of Aryl Hydrocarbon Receptor
Ikuta, T., Kobayashi, Y., & Kawajiri, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310492200 · Cited by 125
7-Ketocholesterol Is an Endogenous Modulator for the Arylhydrocarbon Receptor
Savouret, J., Antenos, M., Quesne, M., Xu, J., Milgröm, E., & Casper, R. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005988200 · Cited by 125
Ligand Selectivity and Gene Regulation by the Human Aryl Hydrocarbon Receptor in Transgenic Mice
Flaveny, C. A., Murray, I. A., Chiaro, C. R., & Perdew, G. H. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.054825 · Cited by 124
Self-citationThe Anti-Inflammatory Drug Leflunomide Is an Agonist of the Aryl Hydrocarbon Receptor
O'Donnell, E. F., Saili, K. S., Koch, D. C., Kopparapu, P. R., Farrer, D., Bisson, W. H., Mathew, L. K., Sengupta, S., Kerkvliet, N. I., Tanguay, R. L., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013128 · Cited by 124
Fukumoto, S., Toshimitsu, T., Matsuoka, S., Maruyama, A., Oh‐oka, K., Takamura, T., Nakamura, Y., Ishimaru, K., Fujii‐Kuriyama, Y., Ikegami, S., et al. (2014) · Immunology and Cell Biology · doi:10.1038/icb.2014.2 · Cited by 122
A role for the aryl hydrocarbon receptor in mammary gland tumorigenesis
Schlezinger, J. J., Liu, D., Farago, M., Seldin, D. C., Belguise, K., Sonenshein, G. E., & Sherr, D. H. (2006) · Biological Chemistry · doi:10.1515/bc.2006.145 · Cited by 122
Bock, K. W., & Köhle, C. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.02.004 · Cited by 119
DiNatale, B. C., Schroeder, J. C., Francey, L. J., Kusnadi, A. R., & Perdew, G. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.118570 · Cited by 117
Self-citationVogel, C. F. A., Wu, D., Goth, S. R., Baek, J., Lollies, A., Domhardt, R., Grindel, A., & Pessah, I. N. (2013) · Immunology and Cell Biology · doi:10.1038/icb.2013.43 · Cited by 117
Kerkvliet, N. I. (2002) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2002.9537 · Cited by 117
Involvement of RelB in aryl hydrocarbon receptor-mediated induction of chemokines
Vogel, C. F. A., Sciullo, E. M., & Matsumura, F. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.09.032 · Cited by 115
Ramadoss, P., & Perdew, G. H. (2004) · Molecular Pharmacology · doi:10.1124/mol.66.1.129 · Cited by 114
Self-citationIdentification of a High-Affinity Ligand That Exhibits Complete Aryl Hydrocarbon Receptor Antagonism
Smith, K. J., Murray, I. A., Tanos, R., Tellew, J. E., Boitano, A. E., Bisson, W. H., Kolluri, S. K., Cooke, M. P., & Perdew, G. H. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.178392 · Cited by 113
Self-citationDegner, S. C., Papoutsis, A. J., Selmin, O. I., & Romagnolo, D. F. (2008) · Journal of Nutrition · doi:10.3945/jn.108.099259 · Cited by 110
Differential Gene Regulation by the Human and Mouse Aryl Hydrocarbon Receptor
Flaveny, C. A., Murray, I. A., & Perdew, G. H. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp308 · Cited by 108
Self-citationThe aryl hydrocarbon receptor inhibits prostate carcinogenesis in TRAMP mice
Fritz, W. A., Lin, T.-M., Cardiff, R. D., & Peterson, R. E. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl179 · Cited by 106
Evidence for Ligand-Mediated Selective Modulation of Aryl Hydrocarbon Receptor Activity
Murray, I. A., Morales, J. L., Flaveny, C. A., DiNatale, B. C., Chiaro, C. R., Gowda, K., Amin, S., & Perdew, G. H. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.061788 · Cited by 104
Self-citationSafe, S. H., & McDougal, A. J. (2002) · International Journal of Oncology · doi:10.3892/ijo.20.6.1123 · Cited by 101
Marshall, N. B., Vorachek, W. R., Steppan, L. B., Mourich, D. V., & Kerkvliet, N. I. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.4.2382 · Cited by 100
Jin, U.-H., Lee, S., & Safe, S. H. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.195339 · Cited by 100
Zhang, S., Kim, K., Jin, U. H., Pfent, C. M., Cao, H., Amendt, B. A., Liu, X., Wilson-Robles, H. M., & Safe, S. H. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0548 · Cited by 100
Epiregulin Is Up-Regulated in Pancreatic Cancer and Stimulates Pancreatic Cancer Cell Growth
Zhu, Z., Kleeff, J. H., Frieß, H., Wang, L., Zimmermann, A., Yarden, Y., Büchler, M. W., & Korc, M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3033 · Cited by 95
Wang, H.-K., Yeh, C., Iwamoto, T., Satsu, H., Shimizu, M., & Totsuka, M. (2012) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf204625y · Cited by 95
Nedd9/Hef1/Cas-L mediates the effects of environmental pollutants on cell migration and plasticity
Bui, L. C., Tomkiewicz, C., Chevallier, A., Pierre, S., Bats, A., Mota, S. I., Raingeaud, J., Pierre, J., Diry, M., Transy, C., et al. (2009) · Oncogene · doi:10.1038/onc.2009.224 · Cited by 94
Zinc finger transcription factor Slug is a novel target gene of aryl hydrocarbon receptor
Ikuta, T., & Kawajiri, K. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.08.002 · Cited by 93
The aryl hydrocarbon receptor as a target for estrogen receptor-negative breast cancer chemotherapy
Zhang, S. J., Lei, P., Liu, X., Li, X., Walker, K., Kotha, L., Rowlands, C., & Safe, S. H. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0054 · Cited by 93
Román, Á., Carvajal-González, J. M., Rico-Leo, E. M., & Fernández‐Salguero, P. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.013292 · Cited by 92
Nucleocytoplasmic Shuttling of the Aryl Hydrocarbon Receptor
Ikuta, T., Tachibana, T., Watanabe, J. A., Yoshida, M., Yoneda, Y., & Kawajiri, K. (2000) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a022633 · Cited by 90
Peng, T., Chen, J., Mao, W., Song, X., & Chen, M. (2009) · BMC Cell Biology · doi:10.1186/1471-2121-10-27 · Cited by 88
Merchant, M., Arellano, L. A. D. L. P., & Safe, S. H. (1990) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(90)90416-v · Cited by 87
Pang, P., Lin, Y., Lee, Y., Hou, H., Hsu, S., & Juan, S. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21299 · Cited by 85
Murray, I. A., Gowda, K., DiNatale, B. C., Flaveny, C. A., Chiaro, C. R., Lin, J.-M., Sharma, A. K., Amin, S., & Perdew, G. H. (2010) · Chemical Research in Toxicology · doi:10.1021/tx100045h · Cited by 84
Self-citationAntagonism of Aryl Hydrocarbon Receptor Signaling by 6,2′,4′-Trimethoxyflavone
Murray, I. A., Flaveny, C. A., DiNatale, B. C., Chairo, C. R., Schroeder, J. C., Kusnadi, A. R., & Perdew, G. H. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.158261 · Cited by 83
Self-citationVogel, C. F. A., Li, W., Sciullo, E. M., Newman, J. W. I., Hammock, B. D., Reader, J. R., Tuscano, J. M., & Matsumura, F. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070406 · Cited by 83
McDougal, A. J., Wilson, C., & Safe, S. H. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)00299-1 · Cited by 82
der Heiden, E. V., Bechoux, N., Müller, M., Sergent, T., Schneider, Y., Larondelle, Y., Maghuin‐Rogister, G., & Scippo, M. (2008) · Analytica Chimica Acta · doi:10.1016/j.aca.2008.09.054 · Cited by 81
Belguise, K., Guo, S., Yang, S., Rogers, A. E., Seldin, D. C., Sherr, D. H., & Sonenshein, G. E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2730 · Cited by 78
The Aryl Hydrocarbon Receptor Directly Regulates Expression of the Potent Mitogen Epiregulin
Patel, R. D., Kim, D. J., Peters, J. M., & Perdew, G. H. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi344 · Cited by 77
Self-citationBlack, M. B., Budinsky, R. A., Dombkowski, A. A., Cukovic, D., LeCluyse, E. L., Ferguson, S., Thomas, R. S., & Rowlands, J. C. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs069 · Cited by 76
Ah Receptor Antagonism Represses Head and Neck Tumor Cell Aggressive Phenotype
DiNatale, B. C., Smith, K. M., John, K., Gowda, K., Amin, S., & Perdew, G. H. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0216 · Cited by 73
Self-citationInfluence of cell cycle on responses of MCF-7 cells to benzo[a]pyrene
Hamouchene, H., Arlt, V. M., Giddings, I., & Phillips, D. H. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-333 · Cited by 72
Steffan, R. J., Matelan, E. M., Ashwell, M. A., Moore, W., Solvibile, W. R., Trybulski, E. J., Chadwick, C. C., Chippari, S. M., Kenney, T. F., Eckert, A., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049194+ · Cited by 70
Time on Dialysis and Cancer Risk After Kidney Transplantation
Wong, G., Turner, R. M., Chapman, J. R., Howell, M., Lim, W. H., Webster, A. C., & Craig, J. C. (2012) · Transplantation · doi:10.1097/tp.0b013e31827743b4 · Cited by 70
Vogel, C. F. A., Li, W., Wu, D., Miller, J. K., Sweeney, C. A., Lazennec, G., Fujisawa, Y., & Matsumura, F. (2011) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2011.05.011 · Cited by 68
DiNatale, B. C., Schroeder, J. C., & Perdew, G. H. (2010) · Molecular Carcinogenesis · doi:10.1002/mc.20702 · Cited by 68
Self-citationJohn, K., Lahoti, T. S., Wagner, K., Hughes, J. M., & Perdew, G. H. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.22032 · Cited by 66
Self-citationASC-associated inflammation promotes cecal tumorigenesis in aryl hydrocarbon receptor-deficient mice
Ikuta, T., Kobayashi, Y., Kitazawa, M., Shiizaki, K., Itano, N., Noda, T., Pettersson, S., Poellinger, L., Fujii‐Kuriyama, Y., Taniguchi, S., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt083 · Cited by 66
Cho, Y. C., Zheng, W., & Jefcoate, C. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2003.12.025 · Cited by 66
A Proposed Mechanism for the Protective Effect of Dioxin against Breast Cancer
Hsu, E. L., Yoon, D. S., Choi, H. H., Wang, F., Taylor, R. T., Chen, N., Zhang, R., & Hankinson, O. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm125 · Cited by 65
Aryl hydrocarbon receptor-mediated cell cycle control.
Elferink, C. J. (2003) · PubMed · Cited by 62
AhR expression is increased in hepatocellular carcinoma
Liu, Z., Wu, X., Zhang, F., Han, L., Bao, G., He, X., & Xu, Z. (2013) · Journal of Molecular Histology · doi:10.1007/s10735-013-9495-6 · Cited by 60
Punj, S., Kopparapu, P., Jang, H. S., Phillips, J. L., Pennington, J. M., Rohlman, D., O’Donnell, E. F., Iversen, P. L., Kolluri, S. K., & Kerkvliet, N. I. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088726 · Cited by 60
Han, Z., Miwa, Y., Obikane, H., Mitsumata, M., Takahashi‐Yanaga, F., Morimoto, S., & Sasaguri, T. (2007) · Cardiovascular Research · doi:10.1093/cvr/cvm095 · Cited by 60
Karmaus, A. L., Dere, E., Angrish, M. M., & Zacharewski, T. R. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft028 · Cited by 60
A biological basis for depression in pancreatic cancer
Botwinick, I. C., Pursell, L., Yu, G., Cooper, T. B., Mann, J. J., & Chabot, J. A. (2014) · HPB · doi:10.1111/hpb.12201 · Cited by 57
AHR signaling in prostate growth, morphogenesis, and disease
Vezina, C. M., Lin, T., & Peterson, R. E. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.09.039 · Cited by 56
Induction and activation of the aryl hydrocarbon receptor by IL-4 in B cells
Tanaka, G., Kanaji, S., Hirano, A., Arima, K., Shinagawa, A., Goda, C., Yasunaga, S., Ikizawa, K., Yanagihara, Y., Kubo, M., et al. (2005) · International Immunology · doi:10.1093/intimm/dxh260 · Cited by 55
Darrasse-Jèze, G., & Podsypanina, K. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00292 · Cited by 54
Murray, I. A., Flaveny, C. A., Chiaro, C. R., Sharma, A. K., Tanos, R. S., Schroeder, J. C., Amin, S. G., Bisson, W. H., Kolluri, S. K., & Perdew, G. H. (2011) · Molecular Pharmacology · doi:10.1124/mol.110.069369 · Cited by 53
Self-citationThe Aryl Hydrocarbon Receptor Is Constitutively Active in Advanced Prostate Cancer Cells
Richmond, O. H., Ghotbaddini, M., Allen, C., Walker, A., Zahir, S. T., & Powell, J. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095058 · Cited by 53
Lahoti, T. S., Hughes, J. M., Kusnadi, A. R., John, K., Zhu, B., Murray, I. A., Gowda, K., Peters, J. M., Amin, S., & Perdew, G. H. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.209726 · Cited by 53
Self-citationThe mouse and human Ah receptor differ in recognition of LXXLL motifs
Flaveny, C. A., Reen, R. K., Kusnadi, A. R., & Perdew, G. H. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.01.014 · Cited by 51
Self-citationFunatake, C. J., Marshall, N. B., & Kerkvliet, N. I. (2008) · Journal of Immunotoxicology · doi:10.1080/15476910802019037 · Cited by 49
Wihlén, B., Ahmed, S., Inzunza, J., & Matthews, J. B. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0396 · Cited by 49
Madak‐Erdogan, Z., & Katzenellenbogen, B. S. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr300 · Cited by 49
Spink, D. C., Johnson, J. A., Connor, S., Aldous, K. M., & Gierthy, J. F. (1994) · Journal of Toxicology and Environmental Health · doi:10.1080/15287399409531856 · Cited by 47
Stark, K., Burger, A. M., Wu, J., Shelton, P. M., Polin, L., & Li, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074525 · Cited by 46
Brembilla, N. C., Ramirez, J., Chicheportiche, R., Sorg, O., Saurat, J. ‐., & Chizzolini, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018741 · Cited by 45
Aryl Hydrocarbon Receptor in Breast Cancer—A Newly Defined Prognostic Marker
Saito, R., Miki, Y., Hata, S., Takagi, K., Iida, S., Oba, Y., Ono, K., Ishida, T., Suzuki, T., Ohuchi, N., et al. (2013) · Hormones and Cancer · doi:10.1007/s12672-013-0160-z · Cited by 44
Aryl hydrocarbon receptor ligands repress T-cadherin expression in vascular smooth muscle cells
Niermann, T., Schmutz, S., Erné, P., & Resink, T. J. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02970-4 · Cited by 43
Kennedy, G. D., Nukaya, M., Moran, S. M., Glover, E., Weinberg, S., Balbo, S., Hecht, S. S., Pitot, H. C., Drinkwater, N. R., & Bradfield, C. A. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu065 · Cited by 42
Farrell, K., Safe, L. M., & Safe, S. H. (1987) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(87)90485-1 · Cited by 42
Evidence that ligand binding is a key determinant of Ah receptor-mediated transcriptional activity
Murray, I. A., Reen, R. K., Leathery, N., Ramadoss, P., Bonati, L., Gonzalez, F. J., Peters, J. M., & Perdew, G. H. (2005) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2005.07.014 · Cited by 41
Self-citationKamata, N., Takechi, M., Mitani, Y., Ohta, K., Fujimoto, S., 平岡, 美., Higashikawa, K., & Shigeishi, H. (2008) · Oncology Reports · doi:10.3892/or.19.6.1557 · Cited by 41
Wang, C., Chang, H., Chen, P., Chang, J. T., Kuo, Y.-C., Ko, J., & Lin, P. (2009) · International Journal of Cancer · doi:10.1002/ijc.24348 · Cited by 38
Chuang, C.-Y., Chang, H., Lin, P., Sun, S., Chen, P., Lin, Y.-Y., Sheu, G., Ko, J., Hsu, S., & Chang, J. T. (2011) · Gene · doi:10.1016/j.gene.2011.10.019 · Cited by 33
Fardel, O. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.738194 · Cited by 33
Connor, K. T., Harris, M. A., Edwards, M. R., Budinsky, R. A., Clark, G. C., Chu, A. C., Finley, B. L., & Rowlands, J. C. (2007) · Journal of Exposure Science & Environmental Epidemiology · doi:10.1038/sj.jes.7500607 · Cited by 32
Amphiregulin and epiregulin expression in neoplastic and inflammatory lesions in the colon
Nishimura, T., Andoh, A., Inatomi, O., et al. (2008) · Oncology Reports · doi:10.3892/or.19.1.105 · Cited by 32
Common Commercial and Consumer Products Contain Activators of the Aryl Hydrocarbon (Dioxin) Receptor
Zhao, B., Bohonowych, J. E. S., Timme‐Laragy, A. R., Jung, D., Affatato, A. A., Rice, R. H., Giulio, R. T. D., & Denison, M. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056860 · Cited by 30
The aryl hydrocarbon receptor in tumor immunity
Platten, M., Litzenburger, U. M., & Wick, W. (2012) · OncoImmunology · doi:10.4161/onci.19071 · Cited by 30
Yin, X., Chen, J., Mao, W., Wang, Y., & Chen, M. (2013) · Oncology Reports · doi:10.3892/or.2013.2410 · Cited by 28
Furman, D. P., Oshchepkova, E. A., Oshchepkov, D. Y., et al. (2009) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2009.10.004 · Cited by 27
Fernández‐Salguero, P. M. (2010) · Cell Adhesion & Migration · doi:10.4161/cam.4.2.10387 · Cited by 27
韓, 志. (2008) · Medical Entomology and Zoology · Cited by 24
Terashima, J., Habano, W., Gamou, T., & Ozawa, S. (2011) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-11-rg-054 · Cited by 23
Kolasa, É., Houlbert, N., Balaguer, P., & Fardel, O. (2013) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2013.01.005 · Cited by 18
Schlezinger, J. J., Bernard, P. L., Haas, A., Grandjean, P., Weihe, P., & Sherr, D. H. (2009) · Environmental Health Perspectives · doi:10.1289/ehp.0901113 · Cited by 15
Jensen, B. A., Reddy, C. M., Nelson, R. K., & Hahn, M. E. (2010) · Aquatic Toxicology · doi:10.1016/j.aquatox.2010.07.021 · Cited by 13
Cited by
Lactobacillus reuteri induces gut intraepithelial CD4 + CD8αα + T cells
Cervantes-Barragan, L., Chai, J. N., Tianero, M. D., Di Luccia, B., Ahern, P. P., Merriman, J., Cortez, V. S., Caparon, M. G., Donia, M. S., Gilfillan, S., et al. (2017) · Science · doi:10.1126/science.aah5825 · Cited by 896
Hezaveh, K., Shinde, R. S., Klötgen, A., Halaby, M. J., Lamorte, S., Ciudad, M. T., Quevedo, R., Neufeld, L., Liu, Z. Q., Jin, R., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.01.006 · Cited by 746
Gut mucosal microbiome across stages of colorectal carcinogenesis
Nakatsu, G., Li, X., Zhou, H., Sheng, J., Wong, S. H., Wu, W. K. K., Ng, S. C., Tsoi, H., Dong, Y., Zhang, N., et al. (2015) · Nature Communications · doi:10.1038/ncomms9727 · Cited by 701
Microbial tryptophan metabolites regulate gut barrier function via the aryl hydrocarbon receptor
Scott, S. A., Fu, J., & Chang, P. V. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2000047117 · Cited by 696
Natividad, J. M., Agus, A., Planchais, J., Lamas, B., Jarry, A. C., Martin, R., Michel, M.-L., Chong-Nguyen, C., Roussel, R., Straube, M., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.07.001 · Cited by 642
Metadata
- Authors
- Murray, I. A., Patterson, A. D., & Perdew, G. H.
- Venue
- Nature Reviews Cancer
- Published
- 2014-11-24
- Volume
- 14
- Issue
- 12
- Pages
- 801-814
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1996613294
- Cited by
- 883
- References
- 169
- FWCI
- 6.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.